The effect of fibrinogen substitution on reversal of dilutional coagulopathy: An in vitro model

Anesthesia and Analgesia

Volumn 102, Issue 2, 2006, Pages 347-351

  Fries, Dietmar ^a   Innerhofer, Petra ^a   Reif, Christian ^a   Streif, Werner ^a   Klingler, Anton ^a   Schobersberger, Wolfgang ^b   Velik Salchner, Corinna ^a   Friesenecker, Barbara ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY FOR HEALTH SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOGEN; GELATIN SUCCINATE; GELOFUSIN; HETASTARCH; RINGER LACTATE SOLUTION;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; BLOOD SAMPLING; COLLOID; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTALLOID; DILUTION; DILUTIONAL COAGULOPATHY; DOSE RESPONSE; FIBRIN POLYMERIZATION; FLUID THERAPY; HUMAN; HUMAN EXPERIMENT; HYPOVOLEMIA; IN VITRO STUDY; INJURY; MALE; MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL; SUBSTITUTION THERAPY; THROMBOCYTE; THROMBOELASTOGRAPHY;

EID: 31444453139     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000194359.06286.d4     Document Type: Article

References (29)

1. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: reassessment. J Trauma 1995;38:185-93.
2. Acosta JA, Yang JC, Winchell RJ, et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998;186: 528-33.
3. McLeod J, Lynn M, McKenney M, et al. Early coagulopathy predicts mortality in trauma. J Trauma 2003;55:39-44.
4. Hiippala S. Replacement of massive blood loss. Vox Sang 1998; 74:399-407.
5. Leslie SD, Toy PT. Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am J Clin Pathol 1991;96:770-3.
6. Murray DJ, Olson J, Strauss R, Tinker JH. Coagulation changes during packed red cell replacement of major blood loss. Anesthesiology 1988;69:839-45.
7. Counts RB, Haisch C, Simon TL, et al. Hemostasis in massively transfused trauma patients. Ann Surg 1979;190:91-9.
8. Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995;81:360-5.
9. Innerhofer P, Fries D, Margreiter J, et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002;95:858-65.
10. Gerlach R, Tölle F, Raabe A, et al. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased FXIII activity. Stroke 2002;33:1618-23.
11. Mallet SV, Cox DJA. Thrombelastography. Br J Anaesth 1992; 62:307-13.
12. Entholzner EK, Mielke LL, Calatzis AN, et al. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand 2000;44:1116-21.
13. Haisch G, Boldt J, Krebs C, et al. The influence of intravascular therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 2001;92:565-71.
14. Calatzis AN, Fritzsche P, Calatzis AI, et al. An analysis of the correlation of the ROTEG coagulation analyzer and the Hellige Thrombelastograph D. Ann Hematol 1996;72:P87.
15. Calatzis AN, Kling M, Sternberger A, et al. Pitfalls in the application of TEG during liver transplantation and ways to escape. Ann Hematol 1995;70:P83.
16. Calatzis AN, Kling M, Calatzis AL, et al. Fast and specific coagulation monitoring through modified thrombelastography. Ann Hematol 1996;72:P92.
17. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solution in critically ill patients: a systemic review of randomized trials. BMJ 1998;316:961-4.
18. Mardel SN, Saunders FM, Allen H, et al. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 1998;80:204-7.
19. Madjdpour C, Dettori N, Frascarolo P, et al. Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics? Br J Anaesth 2005;94:569-76.
20. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999;25: 258-68.
21. Fries D, Innerhofer P, Klingler A, et al. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg 2002;94: 1280-7.
22. Heindl B, Delorenzo C, Spannagl M. High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion. Anaesthesist. In press.
23. Fenger-Eriksen C, Anker-Moller E, Heslop J, et al. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005;94:324-9.
24. Fries D, Krismer A, Klingler A, et al. The effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth. In press.
25. Singbartl K, Innerhofer P, Radvan J, et al. Hemostasis and hemodilution: a quantitative mathematical guide for clinical practice. Anesth Analg 2003;96:929-35.
26. McLoughlin TM, Fontana JL, Alving B, et al. Profound normovolemic hemodilution: hemostatic effects in patients and in a porcine model. Anesth Analg 1996;83:459-65.
27. Rumley A, Woodward M, Hoffmeister A, et al. Comparison of plasma fibrinogen by Clauss, prothrombin-derived, and immunoephelometric assays in a general population: implications for risk stratification by thirds of fibrinogen. Blood Coagul Fibrinolysis 2002;14:197-201.
28. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995;6:743-6.
29. Lang T, Bauters A, Braun SL, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005;16:301-10.